Paediatric TB Medicines Shortage Raises Alarm in Pakistan
Health experts have raised serious concerns about a growing ‘paediatric TB medicines shortage’ in Pakistan. The warning came from the Pakistan Medical Association, which says the crisis threatens thousands of children. Doctors fear the shortage could trigger a dangerous rise in drug-resistant tuberculosis.
Reports from hospitals across the country show a worrying trend. Many facilities say stocks of first-line paediatric tuberculosis drugs are nearly gone. As a result, treatment for young patients faces serious disruption.
Pakistan already carries one of the highest tuberculosis burdens globally. Therefore, interruptions in treatment could worsen the public health situation. Health professionals warn that children remain the most vulnerable group.
Growing Risk of Drug-Resistant Tuberculosis
Doctors say consistent treatment is essential for tuberculosis patients. However, medicine shortages break the treatment cycle and weaken recovery chances.
When treatment stops or becomes irregular, bacteria can survive and mutate. As a result, patients face higher risks of multi-drug resistant TB. This condition is harder and more expensive to treat.
According to the Pakistan Medical Association, Pakistan already struggles with a high rate of drug-resistant tuberculosis among previously treated patients. Therefore, further interruptions could increase the number of severe cases.
Children face even greater danger. Without regular medication, tuberculosis may spread beyond the lungs. In some cases, the infection can reach the brain or bloodstream.
Supply Issues and Production Challenges
Many people believe Pakistan does not produce tuberculosis medicines locally. However, experts say the situation is more complex. Several local pharmaceutical companies previously manufactured TB drugs. In fact, one national company even received prequalification from the World Health Organization for a drug-resistant TB treatment.
Despite this progress, production slowed due to pricing disputes. Rising costs of raw materials made manufacturing difficult while price caps remained unchanged. Consequently, some companies halted production, which increased dependence on imported medicines.
Calls for Urgent Government Action
Health experts now urge immediate action to address the shortage. They recommend emergency imports of paediatric TB medicines to stabilize supplies. In addition, officials want a transparent audit of current drug stocks. This step could ensure fair distribution across hospitals and provinces.
Doctors also stress the need for stronger supply planning within the National TB Programme. Without quick action, the shortage may grow into a national health crisis.
